Form 4: NovoCure Executive Frank X. Leonard Sells Shares to Cover Tax Obligations
SEC Form 4
Frank X. Leonard, EVP and President of Novocure Oncology, sold 2,527 ordinary shares of NovoCure Ltd to cover tax withholding obligations related to the vesting of Restricted Stock Units.
Summary
- On March 3, 2025, Frank X. Leonard, an executive at NovoCure Ltd, sold 2,527 ordinary shares.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- The shares were sold at a weighted average price of $18.5363, with individual trades ranging from $18.02 to $18.9918.
- Following the transaction, Leonard directly owns 143,673 ordinary shares.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Executive share sales for tax obligations are a common practice and generally don't indicate a change in the executive's outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the share sale transaction. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.